STAAR Surgical Company (STAA)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$23.47-0.47%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · STAA
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(25.0) + peer(0.2*0.0) + term(0.0) → 8.75% (capped ±15.0)
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 12, 2026, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended July 3, 2026, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 13, 2026, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended April 3, 2026, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On March 3, 2026, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter and year ended January 2, 2026, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On November 5, 2025, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended September 26, 2025, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference. The information furnished herewith pursuant to
Results of Operations and Financial Condition. On October 20, 2025, STAAR Surgical Company (the “Company”) published a press release reporting its preliminary net sales results for the quarter ended September 26, 2025, a copy of which is filed as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On August 6, 2025, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended June 27, 2025, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference. The information furnished herewith pursuant to
Results of Operations and Financial Condition. On May 7, 2025, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended March 28, 2025, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On February 11, 2025, 2024, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter and year ended December 27, 2024, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On October 30, 2024, STAAR Surgical Company (the “Company”) reported its financial results for the quarter ended September 27, 2024, and filed a Current Report on Form 8-K (the “Original Form 8-K”), which included the Company’s earnings press release as Exhibit 99.1 and the Company’s slide presentation as Exhibit 99.2. As further discussed below in Item 7.01, the Company is filing this Current Report on Form 8-K/A to amend the Original Form 8-K t…
Results of Operations and Financial Condition. On October 30, 2024, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended September 27, 2024, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On August 7, 2024, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended June 28, 2024, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On May 7, 2024, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended March 29, 2024, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
Results of Operations and Financial Condition. On April 4, 2024, STAAR Surgical Company (the “Company”) published a press release reporting preliminary net sales for the first quarter ended March 29, 2024, a copy of which is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by this reference. The financial information is preliminary and subject to adjustment in the final financial statements to be filed with the Company’s Quarterly Report on Form 10-Q for the three m…